【レポートの概要（一部）】
1. Report Overview
1. Report Overview
1.1 Global Pre-Filled Syringes Market Overview
1.2 Global Pre-Filled Syringes Market Segmentation
1.3 Why You Should Read This Report
1.4 How This Report Delivers
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report For?
1.7 Methodology
1.8 Frequently Asked Questions (FAQ)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2. Introduction to Pre-Filled Syringes
2.1 What are Pre-Filled Syringes?
2.1.1 A Brief History of Pre-Filled Syringes
2.2 Design and Manufacture of Pre-Filled Syringes
2.2.1 Glass and Plastic Syringes
2.2.2 Safety and the Pre-Filled Syringe Market
2.2.3 Concerns over Needlestick Injuries
2.3 An Introduction to Pen Injectors and Autoinjectors
2.3.1 Pen Injectors and Autoinjectors Offer Advantages in Self-Administration
2.3.2 What Determines Injection Device Choice?
2.4 Glass versus Plastic
2.4.1 Glass
2.4.2 Plastic
2.5 Future Directions for Pre-Filled Syringes
2.6 Pre-Filled Syringes: Market Segmentation
2.7 Scope of this Report
2.7.1 Products Excluded from this Report
2.8 Currency Exchange Rates in This Report
3. Pre-Filled Syringes: World Market 2015-2025
3.1 Pre-Filled Syringes as a Share of the Global Drug Delivery Market
3.2 The World Pre-Filled Syringes Market in 2013 and 2014
3.2.1 World Pre-Filled Syringes Market: Market Shares by Segment 2013
3.2.2 Leading Companies in the Pre-Filled Syringes Market
3.3 World Pre-Filled Syringes Market: Sales Forecast by Value, 2015-2025
3.4 World Pre-Filled Syringes Market: Sales Forecast by Volume, 2015-2025
3.5 How Will Segmental Market Shares Change to 2025?
3.6 World Pre-Filled Syringes Market: Drivers and Restraints 2015-2025
3.6.1 Biologics and Biosimilars to Drive Market Growth
3.6.2 Human Factors and Regulatory Requirements
3.6.3 Advances in Pre-Filled Syringe Manufacturing
3.6.4 Market Genericisation and Pre-Filled Syringes
3.6.5 The Injectable Drug Pipeline is Substantial
3.6.6 Competing Drug Delivery Technologies
3.7 Glass Pre-Filled Syringes Lead the Pre-Filled Syringes Market
3.7.1 Glass Pre-Filled Syringes Market: Sales Forecast by Value, 2015-2025
3.7.2 Glass Pre-Filled Syringes Market: Sales Forecast by Volume, 2015-2025
3.7.3 Glass Pre-Filled Syringes: Drivers and Restraints 2015-2025
3.8 Plastic Pre-Filled Syringes: Rapid Growth Forecasted
3.8.1 Plastic Pre-Filled Syringes Market: Sales Forecast by Value, 2015-2025
3.8.2 Plastic Pre-Filled Syringes Market: Sales Forecast by Volume, 2015-2025
3.8.3 Plastic Pre-Filled Syringes: Drivers and Restraints 2015-2025
3.9 Pen Injectors and Autoinjectors: A Growing Segment
3.9.1 Pen Injectors and Autoinjectors Market: Sales Forecast by Value, 2015-2025
3.9.2 Pen Injectors and Autoinjectors Market: Sales Forecast by Volume, 2015-2025
3.9.3 Pen Injectors and Autoinjectors: Drivers and Restraints 2015-2025
3.9.4 Insulin and Other Biologics to Lead Market Growth
4. Leading National and Regional Markets 2015-2025
4.1 National Breakdown of the World Pre-Filled Syringes Market
4.2 World Pre-Filled Syringes Market: National Markets Forecast 2015-2025
4.2.1 How Will National Market Shares Change to 2025?
4.3 Regional Breakdown of the World Pre-Filled Syringes Market
4.4 World Pre-Filled Syringes Market: Regional Markets Forecast 2015-2025
4.4.1 How Will Regional Market Shares Change to 2025?
4.5 US Pre-Filled Syringes Market Forecast 2015-2025
4.5.1 US Pre-Filled Syringes Market: Trends and Developments
4.5.1.1 New Drug and Device Launches to Drive Growth to 2025
4.5.1.2 The Budget Control Act 2011 and the Medical Excise Tax
4.6 Japanese Pre-Filled Syringes Market Forecast 2015-2025
4.7 EU5 Pre-Filled Syringes Market Forecast 2015-2025
4.8 Emerging Markets: Pre-Filled Syringes Market Forecast 2015-2025
4.8.1 Pre-Filled Syringe Manufacturers Are Investing in Emerging Markets
4.8.2 Chinese Pre-Filled Syringes Market Forecast 2015-2025
4.8.2.1 China’s Five Year Plans Prioritise Biotechnology
4.8.3 Indian Pre-Filled Syringes Market Forecast 2015-2025
4.8.4 Russian Pre-Filled Syringes Market Forecast 2015-2025
4.8.5 Brazilian Pre-Filled Syringes Market Forecast 2015-2025
4.8.6 Mexican Pre-Filled Syringes Market Forecast 2015-2025
5. Leading Therapeutic Sectors for Pre-Filled Syringes 2015-2025
5.1 Leading Therapeutic Sectors for Pre-Filled Syringes and Other Injection Devices in 2014
5.1.1 Vaccines and Heparins Are Major Market Sectors
5.1.2 Rising Demand in Chronic Conditions: Autoimmune Diseases and Diabetes
5.1.3 Growth for Key Market Sectors 2015-2025
5.2 Pre-Filled Syringes and Pen Injectors for Diabetes 2015-2025
5.2.1 Insulin Market Forecast 2015-2025
5.2.2 High Rates of Pen Injector Use in the EU and Japan
5.2.3 Insulin Pumps: A Technology to Challenge Pen Injectors to 2025?
5.2.4 MannKind’s Afrezza: Inhalable Insulin Approved in US
5.2.5 Biosimilar Insulin to Reach the Market in 2015?
5.2.5.1 Injection Devices for Biosimilar Insulin Products
5.3 Rheumatoid Arthritis: Leading Biologics Dominate the Market
5.3.1 Rheumatoid Arthritis Market Forecast 2015-2025
5.3.2 All Major Injectable Therapies Are Marketed in Proprietary Devices
5.3.3 Novel Injection Systems for RA: Meeting the Needs of Patients
5.3.4 The Receding Threat from Oral Therapies to 2025
5.4 Self-Injection for Multiple Sclerosis: Outlook 2015-2025
5.4.1 Multiple Sclerosis Market Forecast 2015-2025
5.4.2 All Interferon Betas Available in Autoinjectors from 2014
5.4.3 Oral Therapies to Drive MS Market Growth in this Decade
5.5 Growth Hormones: Outlook to 2025
5.5.1 Growth Hormones Market Forecast 2015-2025
5.5.2 Biosimilar Growth Hormones and Pen Injectors
5.5.3 Uptake of Needle-Free Injectors for Growth Hormones
5.6 Pre-Filled Heparin Syringes 2015-2025
5.6.1 One Brand Led the Heparin Market in 2014
5.6.2 Pre-Filled Syringes for LMWHs
5.6.3 Heparin Market Forecast 2015-2025
5.6.4 Follow-On Heparins: Biosimilars or Generics?
5.7 The Vaccine Market Outlook 2015-2025
5.7.1 Vaccine Market Forecast 2015-2025
5.7.2 Single-Use Devices for Vaccine Delivery
5.7.2.1 BD Uniject: A Private-Public Collaboration
5.7.3 Needle-Free Injectors for Vaccines
5.7.4 Other Trends in Vaccine Delivery
5.8 PCSK9 Inhibitors: The Next Advance in Cholesterol-Lowering Drugs
5.8.1 PCSK9 Inhibitors Market Forecast 2015-2025
5.8.2 PCSK9 Inhibitors and Pre-Filled Syringes/Injectors
6. Leading Pre-Filled Device Therapies 2015-2025
6.1 Leading Insulin Therapies Using Pen Injectors 2015-2025
6.1.1 Lantus: The World’s Best-Selling Insulin Analogue
6.1.1.1 SoloSTAR, ClikSTAR and AllSTAR: Three Pen Injectors for Lantus
6.1.1.2 Lantus: Sales Forecast 2015-2025
6.1.2 NovoLog: The Leading Fast-Acting Insulin
6.1.2.1 NovoLog FlexPen: To Be Retired
6.1.2.2 Novo’s New FlexTouch Pen Launched
6.1.2.3 NovoLog: Sales Forecast 2015-2025
6.1.3 Humalog
6.1.3.1 Humalog: HumaPen and KwikPen
6.1.3.2 Humalog: Sales Forecast 2015-2025
6.2 Top Biologics for Rheumatoid Arthritis: Device Outlook to 2025
6.2.1 Humira: The Biggest-Selling Drug in 2013
6.2.1.1 The Humira Pen Is an Innovative Delivery Device
6.2.1.2 Humira: Sales Forecast 2015-2025
6.2.2 Enbrel: The Leading Competitor to Humira
6.2.2.1 Pre-Filled Injection Devices Available for Enbrel in 2014
6.2.2.2 Enbrel: Sales Forecast 2015-2025
6.3 Multiple Sclerosis: Leading Injectable Therapies 2015-2025
6.3.1. Copaxone: An Injectable Non-Interferon Therapy
6.3.1.1 Copaxone Uses Owen Mumford’s Autoject 2 Autoinjector
6.3.1.2 Next-Generation Copaxone and Generics Expected in 2015
6.3.1.3 Copaxone: Sales Forecast 2015-2025
6.3.2 Avonex
6.3.2.1 Biogen Idec Launched the Avonex Pen in 2011
6.3.2.2 Avonex: Sales Forecast 2015-2025
6.3.3 Rebif
6.3.3.1 Rebif Self-Injection Options: Rebiject II, RebiSmart and RebiDose
6.3.3.2 Rebif: A Similar Outlook to Avonex to 2025?
6.4 Growth Hormones: Two Products Dominated the Market in 2014
6.4.1 Norditropin: the Leading Growth Hormone
6.4.1.1 Norditropin: Sales Forecast 2015-2025
6.4.2 Genotropin: Sales Forecast 2015-2025
6.5 Outlook for Leading Heparin Products 2015-2025
6.5.1 Lovenox: Generic Competition in the US Since 2010
6.5.1.1 Lovenox: Sales Forecast 2015-2025
6.5.2 Fragmin Faces Rivalry from Generic Competition to Lovenox
6.5.2.1 Fragmin: Sales Forecast 2015-2025
6.5.3 Arixtra: Aspen and Mylan Hold Marketing Rights
6.5.3.1 Arixtra: Sales Forecast 2015-2025
7. Leading Pre-Filled Syringe and Related Technology Manufacturers, 2015
7.1 Leading Pre-Filled Syringe Manufacturers in 2014
7.1.1 BD: The Market Leader
7.1.1.1 BD: Pre-Filled Syringes Product Portfolio
7.1.1.2 BD: Market Outlook 2015-2025
7.1.1.3 Recent Acquisitions by BD
7.1.1.4 BD Merging with CareFusion
7.1.1.5 BD AutoShield Duo Pen Needle Launched in 2014
7.1.2 Gerresheimer
7.1.2.1 Gerresheimer: Pre-Filled Syringes Product Portfolio
7.1.2.2 Gerresheimer: Market Outlook 2015-2025
7.1.2.3 Gerresheimer: Products in Development
7.1.2.4 Patent Application for Gerresheimer’s Gx G-Fix Adapter
7.1.2.5 Gerresheimer Commissioned to Manufacture Simponi Autoinjectors?
7.1.2.6 Gerresheimer Opens First Development Center in China
7.1.3 Schott
7.1.3.1 Schott: Pre-Filled Syringes Product Portfolio
7.1.3.2 Schott: Market Outlook 2015-2025
7.1.3.3 Schott: Expansion in India
7.2 Other Notable Pre-Filled Syringe Manufacturers
7.2.1 Baxter: Providing Contract Manufacturing with Pre-Filled Syringes
7.2.2 Nipro: Leading Japanese Contract Manufacturer
7.2.2.1 Nipro’s 2012 Acquisition of MGlas
7.2.3 Stevanato Group/Ompi: Insulin Vials Market Leader
7.2.3.1 Ompi’s Ambitious Geographical Expansion Planned to 2016
7.2.4 Weigao: Pre-Filled Syringes for China and Beyond
7.2.5 Unilife: Pre-Filled Safety Syringes
7.2.6 Roselabs: Entered the Market in 2012
7.2.7 Vetter Pharma: Offering Lyo-Ject Dual-Chamber Syringes
7.2.8 Other Companies
7.3 Leading Pen Injector and Autoinjector Manufacturers in 2014
7.3.1 SHL Group
7.3.1.1 SHL Group: Pen Injectors and Autoinjectors Product Portfolio
7.3.1.2 SHL Group: Market Outlook 2015-2025
7.3.2 Ypsomed
7.3.2.1 Ypsomed: Pen Injectors and Autoinjectors Product Portfolio
7.3.2.2 Ypsomed: Market Outlook 2015-2025
7.3.2.3 Ypsomed: Recent Developments
7.3.3 Haselmeier
7.3.3.1 Haselmeier: Pen Injectors and Autoinjectors Product Portfolio
7.3.3.2 Haselmeier: Market Outlook 2015-2025
7.3.4 Owen Mumford
7.3.4.1 Owen Mumford: Pen Injectors and Autoinjectors Product Portfolio
7.3.4.2 Owen Mumford: Market Outlook 2015-2025
7.3.5 Bespak: Entering the Auto-Injectors Market
7.3.6 Other Leading and Emerging Autoinjector Manufacturers
7.4 Leading Pre-Filled Syringe Component Manufacturers in 2014
7.4.1 Datwyler
7.4.1.1 Datwyler: Market Outlook 2015-2025
7.4.2 West Pharmaceutical Services
7.4.2.1 West Pharmaceutical Services: Market Outlook 2015-2025
8. Qualitative Analysis of the Pre-Filled Syringes Market 2015-2025
8.1 SWOT Analysis of the Pre-Filled Syringes Market
8.2 Strengths
8.2.1 Pre-Filled Syringes and Pen/Autoinjectors Are Used In Chronic Conditions
8.2.2 Device Manufacturers Offer a Range Of Products
8.2.3 Customisation and Product Differentiation
8.2.4 Effective Lifecycle Management
8.3 Weaknesses
8.3.1 Patients with Needle Phobia
8.3.2 Chronic Diseases May Make Pre-Filled Syringes Difficult to Use
8.3.3 Risk of Extractables and Leachables
8.3.4 Higher Cost and Greater Cold Chain and Storage Requirements
8.4 Opportunities
8.4.1 Biosimilars Represent a Growing Market
8.4.2 Viscous and Large-Volume Drugs Require Novel Devices
8.4.3 Technological Developments Expanding Product Portfolios
8.4.4 Many Injectable Drugs in the Pipeline
8.4.5 Growth in Emerging Markets
8.5 Threats
8.5.1 Alternative Technologies: Needle-Free and Bolus Injectors
8.5.2 New Oral Therapies for Many Chronic Conditions
8.5.3 Increasing Regulatory Barriers
8.5.4 Cost Pressures on Healthcare Payers
8.6 STEP Analysis of the Pre-Filled Syringes Market
8.6.1 Social Factors: Rising Disease Incidence and Demand for At-Home Care
8.6.2 Technological Developments: Improved Safety and Administration
8.6.3 Economic Pressures: Pre-Filled Syringes Are Cost Efficient
8.6.3.1 High Barriers to Market Entry Exist
8.6.4 Political Issues: Regulatory Developments for Pre-Filled Syringes
8.7 Regulatory and Safety Outlook for Pre-Filled Syringes, 2015-2025
8.7.1 Needlestick Safety and Prevention
8.7.2 International Regulations for Needlestick Prevention
8.7.2.1 The US: The First Country to Introduce Needlestick Legislation
8.7.2.2 The EU: New Rules from 2013 Onwards
8.7.2.3 Needlestick Safety in Japan 2015-2025
8.7.2.4 Legislation for Needlestick Safety in Emerging Markets
8.7.3 Manufacturers Will Continue to Develop New Devices for Needlestick Prevention
8.7.3.1 Ancillary versus Integrated Safety Devices
8.7.4 Extractables and Leachables
8.7.4.1 Companies Will Reduce Sources of Extractables and Leachables
8.7.4.2 Products that Minimise Extractables and Leachables
8.7.4.3 Protein Aggregation: The Challenge of Biological Drugs
8.7.4.4 Regulatory Requirements for Extractables and Leachables, 2015
8.8 Biologics and the Pre-Filled Syringes Market, 2015-2025
8.8.1 Manufacturing Pre-Filled Syringes for Biologics: Glass versus Plastic
8.8.2 Biologics Provide New Challenges for Device Manufacturers
8.8.2.1 Lyophilised Drugs and Dual-Chamber Devices
8.8.3 Delivery Opportunities for High Viscosity Drugs
8.8.4 Are Biosimilars an Opportunity for Pre-Filled Syringe Manufacturers?
8.9 The Role of Patients in Pre-Filled Syringe Industry Development and Growth
8.9.1 Chronic Disease Incidence 2015-2025
8.9.2 The Rise in At-Home Care
8.9.3 Improving Patient Adherence
8.9.4 Injection Devices Must be Developed for Patient Convenience: Human Factors Engineering
8.10 Technological Developments in Pre-Filled Syringes to 2025
8.10.1 Product Differentiation Will be Vital in Crowded Treatment Markets
8.10.2 Product Customisation: Adapting Injection Devices
8.10.3 Trends in Manufacturing Materials for Pre-Filled Syringes
8.10.4 Competing Technologies Will Challenge Pre-Filled Syringes
8.10.4.1 Will Needle-Free Devices Become a Significant Competing Technology?
8.10.4.2 Patients Prefer Oral Drug Delivery
8.11 Outsourcing in the Pre-Filled Syringe Industry
8.11.1 Contract Medical Device Manufacturing
8.11.2 Contract Filling of Pre-Filled Syringes
9. Research Interviews
9.1 Interview with an Anonymous Expert from a Leading Pre-Filled Syringes Manufacturer
9.1.1 Products and Services Provided
9.1.2 Opportunities in Pre-Filled Syringes
9.1.3 Prominent Therapeutic Areas in 2015-2025
9.1.4 Trends and Developments in Pre-Filled Syringes
9.1.5 Challenges and Future Outlook
9.2 Interview with Gerresheimer AG, Düsseldorf, Germany
9.2.1 Gerresheimer’s Products and Services
9.2.2 Gerresheimer’s Development Center in China for Device Contract Manufacturing
9.2.3 Trends and Developments in Pre-Filled Syringes and Injectors
9.2.4 Will Consulting Become More Important?
9.2.5 Challenges for Manufacturers
9.2.6 The Outlook for Pre-Filled Syringes and Pen/Autoinjectors through 2015-2025
9.3 Interview with Richard Harrison, Business Development Manager, Injectables, Bespak Europe
9.3.1 Bespak
9.3.2 Unmet Needs and Future Directions for Autoinjectors
9.3.3 Challenges in Developing Autoinjectors
9.3.4 Trends from Drug Development Impacting Device Manufacturers
10. Conclusions
10.1 Pre-Filled Syringes and Pen/Autoinjectors: Strong Growth Expected
10.2 The World Pre-Filled Syringes Market in 2014
10.2.1 Current Leading Pre-Filled Syringes Segments
10.2.2 Leading Pre-Filled Syringes Companies
10.2.3 Leading National and Regional Markets
10.3 World Pre-Filled Syringes Market Forecast 2015-2025
10.4 The Future of the Pre-Filled Syringes Market?
10.4.1 Glass Syringes Will Continue to Dominate
10.4.2 Innovation for Growth
11. Glossary
【レポート販売概要】
■ タイトル：プレフィルドシリンジ（薬剤充填済み注射器）の世界市場：ガラス製プレフィルドシリンジ、プラスチック製プレフィルドシリンジ■ 英文：Pre-Filled Syringes Market Forecast 2015-2025 : Prospects for Leading Companies in Plastic Pre-Filled Syringes, Pen Injectors & Autoinjectors, and Glass Pre-Filled Syringes
■ 発行日：2015年2月
■ 調査会社：visiongain
■ 商品コード：VGAIN502205
■ 調査対象地域：グローバル
- 尿失禁ケア製品の世界市場：大人用おむつ、尿道カテーテル、尿失禁スリング、充填剤、尿失禁付属品About Urinary Incontinence Products Urinary incontinence is any involuntary urine leakage; it may occur as a result of a number of deformities, such as abnormal function of the lower urinary tract, overactive bladder, and the result of other illnesses. It is estimated that about 50 percent of women suffer from urinary incontinence at some time in their lives. The prevalence of this in young women …
- パーソナルケア用包装の世界市場The global personal care packaging market is expected to reach $28.1bn in 2018 and develop dynamically over the forecast period, driven by emerging economies. Visiongain scrutinises the 17 leading national markets revealing where the business opportunities are: Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Rest of Asia-Pacific, Rest of Europe, Rest of LAMEA, Russia, South Af …
- 世界の鉱山機械サプライヤーベンチマーク2015Overall trends in the data revealed: • Revenues for Mining Equipment suppliers have fallen sharply since their 2012 peak. • Aftermarket shares of revenues increased substantially between 2012 and 2014. • Caterpillar is widely recognized as the leading equipment supplier. • Account managers, quality maintenance and services, and on-time delivery have significant impacts on supplier selection. • Mor …
- 農業用ドローンの世界市場予測（～2022）The market for agriculture drones is at its growth phase. The market is expected to grow from USD 864.4 Million in 2016 to USD 4,209.2 Million by 2022, at a CAGR of 30.19% between 2016 and 2022. The major factors driving the growth of the agriculture drones market include the increase in funding for UAV manufacturers from the venture firms and the growing awareness about the benefits of agricultur …
- ICT予算及び人員配置動向：教育産業部門 – 企業のICT投資計画Why was the report written? In order to provide a depth of insight into ICT vendors’ and service providers’ potential customers. What is the current market landscape and what is changing? The education sector has come a long way in terms of ICT adoption, from the selective usage of technology to mainstream adoption. The use of ICT promises to change the way that education is imparted, with institu …
- 世界主要国における分子診断市場2015Complete report $34,500. DataPack (test volumes, sales forecasts, supplier shares) $15,900.This new seven-country study from VPGMarketResearch.com contains 1,398 pages, 194 tables, and is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years. Highli …
- 通信向けクラウド課金の世界市場予測（～2021）：課金種類別（統合、前払い、後払い、インターコネクト）、クラウドプラットフォーム別、導入別、需要先別、サービス別、チャージレート別、地域別MarketsandMarkets forecasts the telecom cloud billing market size to grow from USD 2.49 Billion in 2016 to USD 8.22 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 27.0% from 2016 to 2021. Lower operational & administration costs, advancement & increase in adoption of cloud-based technologies, increasing mobile penetration and high subscriber growth, need for real-time billing, and inc …
- 自閉症(Autism)の治療薬パイプライン動向（2015年上半期版）Autism - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Autism - Pipeline Review, H1 2015’, provides an overview of the Autism’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Autism, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (R …
- 免疫タンパク質検査の世界市場2015During the next decade, the immunoprotein testing market will undergo significant transformation. The changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critic …
- 帯状ヘルペス(シングルス)(Herpes Zoster (Shingles))：世界の治験レビュー（2015年上半期版）Herpes Zoster (Shingles) Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Herpes Zoster (Shingles) Global Clinical Trials Review, H1, 2015" provides an overview of Herpes Zoster (Shingles) clinical trials scenario. This report provides top line data relating to the clinical trials on Herpes Zoster (Shingles). Report includes an overview of trial numbers and thei …
- Mobile Virtual Network Enablers 2011: A Study of Functional ViabilityMobile Virtual Network Enabler (MVNE) services represent the backbone of an Mobile Virtual Network Operator (MVNO). These outsourced services include: Data Services, Content Management, Customer Relationship Management, Profile Management, Service Provisioning, Work Fulfillment, Billing, Invoice and Settlement, Revenue and Service Continuity Assurance, and many more. This report analyzes the influ …
- 院内感染症治療薬の世界市場：尿路感染症、気道感染症、血流感染症、手術部位感染症、胃腸感染症About hospital-acquired infections Hospital-acquired diseases are also known as nosocomial infections that are acquired in hospitals and other healthcare facilities. These infections are classified only when a patient is admitted for reasons other than the infections and are caused by bacteria, fungi, parasites, or viruses. Most common types of hospital-acquired infections are SSIs, UTIs, bloodstr …
- 生体吸収性ポリマーの世界市場分析：製品別（ポリ乳酸（PLA）、ポリグリコール酸（PGA）、ポリカプロラクトン、多糖類、タンパク質）、用途別（薬物送達、、整形外科）、競争戦略、セグメント予測、2014-2025The global bioresorbable polymer market is anticipated to reach USD 2.26 billion by 2025, according to a new report by Grand View Research, Inc. The growing demand in the medical sector, owing to its hydrolytically degrading property in the body is projected to increase the global market growth. The increasing health awareness, improving healthcare facilities worldwide and growing surgery procedur …
- イヤホン･ヘッドホンの世界市場分析：製品別（耳内、オーバーイヤー）、技術別（ワイヤー式、ワイヤレス）、価格別（50未満、50～100、100以上）、用途別（フィットネス/スポーツ、ゲーム、VR、音楽）、セグメント予測、2014-2025The global earphones and headphones market is expected to reach USD 15.8 billion by 2025, according to a new research conducted by Grand View Research, Inc. The increasing adoption of earphones/headphones during a workout is primarily expected to drive the earphones & headphones market growth over the coming years. Customers use headphones at their workplaces to enjoy music and other audio content …
- 世界の輸送産業における燃料消費量市場About Fuel Consumption in Transportation Industry Fuel expense is an ongoing expense that must be considered while purchasing a vehicle. It also has a significant impact on the environment, as GHGs, particularly carbon dioxide, are produced when the fuel is burned in an engine. Government programs and local resources largely influence the demand for vehicles and fuel use. Currently, the Transporta …
